W

Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871

Watchlist Manager
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Watchlist
Price: 11.71 CNY -0.26%
Market Cap: 1.9B CNY
Have any thoughts about
Wuhan Hvsen Biotechnology Co Ltd?
Write Note

Wuhan Hvsen Biotechnology Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Wuhan Hvsen Biotechnology Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
W
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Change in Working Capital
-ÂĄ162m
CAGR 3-Years
-22%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Change in Working Capital
-ÂĄ332.3m
CAGR 3-Years
26%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
23%
CAGR 5-Years
-59%
CAGR 10-Years
-16%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Change in Working Capital
-ÂĄ16.8B
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
-14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Change in Working Capital
-ÂĄ5.2B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
-7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Wuhan Hvsen Biotechnology Co Ltd
Glance View

Market Cap
1.9B CNY
Industry
Pharmaceuticals

HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.

Intrinsic Value
22.35 CNY
Undervaluation 48%
Intrinsic Value
Price
W

See Also

What is Wuhan Hvsen Biotechnology Co Ltd's Change in Working Capital?
Change in Working Capital
-162m CNY

Based on the financial report for Dec 31, 2023, Wuhan Hvsen Biotechnology Co Ltd's Change in Working Capital amounts to -162m CNY.

What is Wuhan Hvsen Biotechnology Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-13%

Over the last year, the Change in Working Capital growth was -32%. The average annual Change in Working Capital growth rates for Wuhan Hvsen Biotechnology Co Ltd have been -22% over the past three years , -13% over the past five years .

Back to Top